Project Grant HT94252310630
Award Date
9/30/23
Completion Date
9/29/25
Dollars Obligated
$767K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Kansas City, KS 66160, USA
Similar Awards
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $930,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on March 1, 2024, supports research to investigate the progression of ductal carcinoma in situ (DCIS) to invasive basal-like breast cancer, with a focus on the role of N-RAS. The research aims to advance scientific knowledge and develop innovative therapies in the...
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $1,550,000.00 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, effective April 1, 2025 through March 31, 2029, will support research to investigate "RBP-J Inhibition as a Novel Latency Reversal Strategy for HIV-1-Related Kidney Diseases." This advanced biomedical research project aims to develop...
This $1,395,000 Project Grant award from the Department of Defense's Defense Health Agency was made to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) on April 1, 2024. The grant is funded under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research related to military medicine, with a focus on areas such as cancer and neurological disorders. The purpose of this 3-year grant is to develop a short peptide-based...
This $620,000 Project Grant, awarded on June 15, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) to elucidate the late effects of radiation in head and neck cancer patients. The research aims to advance scientific knowledge and develop innovative therapies in the field of cancer. As a prime federal grant recipient, KUMCRI has an extensive...
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $2,494,712 project grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on August 1, 2024, supports a research project titled "Multisensory Dysfunction Phenotypes as Predictors of Cognitive Impairment and Trajectory After Traumatic Brain Injury." The objective of this four-year grant is to investigate how multisensory...
This federal Project Grant award, totaling $3,560,880, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the public. The primary awardee, the University of Kansas Medical Center Research Institute, Inc. (KUMCRI), will conduct sophisticated scientific investigations to address various medical...
The University of Kansas Medical Center Research Institute, Inc. was awarded a $616,307 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will fund research into the role of bitter taste receptor TAS2R38 in colorectal cancer from July 1, 2021 to June 30, 2024. As the parent organization of the awardee, the University of Kansas will oversee this research being conducted at the awardee's location in...
This $309,528 Project Grant was awarded by the Defense Health Agency on February 1, 2024 under the Military Medical Research and Development program (CFDA 12.420) to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI). The grant supports a project titled "Evaluating the Role of Somatic Mutations in Autosomal Dominant Polycystic Kidney Disease Using Single-Cell Genomics", which aims to advance scientific understanding and treatment of this condition through...
This $309,928 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) to investigate ferritin as a biomarker for progression of autosomal polycystic kidney disease. The 2-year project, which began on February 1, 2024, aims to advance scientific knowledge and develop innovative therapies in this area of kidney disease. KUMCRI, a...
The Defense Health Agency awarded a $4.23 million Project Grant to the University of Kansas Center for Research Inc. under the Military Medical Research and Development federal grant program (CFDA 12.420) to assess eating disorder and comorbidity risk and resilience in a nationally representative sample of recent military enlistees from April 15, 2023 to April 14, 2027. The University of Kansas will lead the research effort to test the performance of a new eating disorder assessment measure in...